Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid Gel for Oral Mucositis in Children on Chemotherapy
NCT05818007Phase 4
Key facts
- Status
- Completed
- Start
- Apr 2022
- Primary completion
- Mar 2023
- Countries
- 1
- Sponsor
- Van Yuzuncu Yil University
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Drugs
- hyaluronic acid
- Conditions
- oral mucositis (OM)
01
Overview
Phase 4, randomised, open-label trial of hyaluronic acid in oral mucositis (OM), sponsored by Van Yuzuncu Yil University. Primary endpoints: World Health Organization Common Toxicity Criteria at 11 days and Visual Analog Scale at 11 days. Started Apr 2022; status: completed.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Hospitalized children receiving chemotherapy with oral mucositis, excluding those with drug allergies.
04
Endpoints
Primary
World Health Organization Common Toxicity Criteria
Visual Analog Scale
Beyond the preview
Go deeper on NCT05818007.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05818007.